Article
Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.
Clinical pharmacology and therapeutics - 1 Oct 2006
Fukudo Masahide, Yano Ikuko, Masuda Satohiro, Goto Maki, Uesugi Miwa, Katsura Toshiya, Ogura Yasuhiro, Oike Fumitaka, Takada Yasutsugu, Egawa Hiroto, Uemoto Shinji, Inui Ken-ichi
Abstract excerpt
OBJECTIVE: Our objective was to investigate the population pharmacokinetics of tacrolimus in pediatric living-donor liver transplant recipients and examine the effects of the multidrug resistance 1 (MDR1) gene and the cytochrome P450 (CYP) genes CYP3A4 and CYP3A5 on the oral clearance of tacrolimus. METHODS: Data were collected retrospectively from 130 de novo pediatric liver transplant recipients treated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
